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Purpose: To identify mutations in the carbohydrate sulfotransferase gene (CHST6) for a Chinese family with macular
corneal dystrophy (MCD) and to investigate the histopathological changes in the affected cornea.
Methods: A corneal button of the proband was obtained by penetrating keratoplasty. The half button and ultrathin sections
from the other half button were examined with special stains under a light microscope (LM) and an electron microscope
(EM) separately. Genomic DNA was extracted from peripheral blood of 11 family members, and the coding region of
CHST6 was amplified by the polymerase chain reaction (PCR) method. The PCR products were analyzed by direct
sequencing and restriction enzyme digestion.
Results: The positive reaction to colloidal iron stain (extracellular blue accumulations in the stroma) was detected under
light microscopy. Transmission electron microscopy revealed the enlargement of smooth endoplasmic reticulum and the
presence of intracytoplasmic vacuoles. The compound heterozygous mutations, c.892C>T and c.1072T>C, were identified
in exon 3 of CHST6 in three patients. The two transversions resulted in the substitution of a stop codon for glutamine at
codon 298 (p.Q298X) and a missense mutation at codon 358, tyrosine to histidine (p.Y358H). The six unaffected family
individuals carried alternative heterozygous mutations. These two mutations were not detected in any of the 100 control
subjects.
Conclusions: Those novel compound heterozygous mutations were thought to contribute to the loss of CHST6 function,
which induced the abnormal metabolism of keratan sulfate (KS) that deposited in the corneal stroma. It could be proved
by the observation of a positive stain reaction and the enlarged collagen fibers as well as hyperplastic fibroblasts under
microscopes.
Macular corneal dystrophy (MCD; OMIM 217800) is an
autosomal  recessive  inherited  disorder  characterized  by
bilateral  progressive  stromal  clouding  and  central  corneal
thinning [1]. The onset usually occurs in the first decade of
life, starting with a fine superficial stromal haze in the central
stroma. Gradually, the opacification extends to the periphery
and  usually  involves  the  entire  cornea,  leading  to  visual
impairment.  At  this  time,  penetrating  keratoplasty  is
necessary.
Although  clinically  indistinguishable,  MCD  has  been
subdivided into three immunophenotypes I, IA, and II, based
on the serum level of sulfated keratan sulfate (KS) measured
by  enzyme-linked  immunosorbent  assay  (ELISA)  and  an
immunohistochemical evaluation of the corneal tissue. The
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serum level of KS and the immunohistochemical reaction to
the cornea is negative in the patients with MCD type I. The
serum level of KS is negative, and the immunohistochemical
reaction to the cornea is positive in the patients with type IA
whereas both are positive in those patients with type II [2-5].
MCD is histologically characterized by the accumulation
of glycosaminoglycans in the stromal lamellae, underneath
the epithelium, and within the keratocytes and endothelial
cells [3,6]. An abnormality in the metabolism of KS has been
implicated in the pathogenesis of MCD.
A gene responsible for MCD types I and II has been
linked to chromosome 16q22 [7-9]. Recently, mutations in a
new carbohydrate sulfotransferase gene (CHST6) encoding
corneal  glucosamine  N-acety-6-sulfotransferase  (C-
GlcNac-6-ST) have been identified [10]. Lack of activity of
this enzyme is thought to result in the production of unsulfated
KS and the loss of transparency in the corneas of affected
patients.  Akama  [10]  and  others  [11-16]  have  described
missense  mutations,  nonsense  mutations,  and  insertions
within the coding region in CHST6 in patients with type I
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700macular corneal dystrophy (differentiation between types I
and IA was not performed) whereas MCD type II is associated
with deletions and rearrangements in the upstream region of
CHST6 as well as missense mutations [10,16-19]. Despite the
variety of mutations [20] reported in both type I and type II
patients, all of the identified sequence changes are associated
with a similar clinical appearance [10-15].
In  this  study,  we  identified  novel  compound
heterozygous mutations within CHST6 in a Chinese family
with MCD and investigated the histopathological changes of
the opaque cornea.
METHODS
Clinical  evaluation:  The  family  was  ascertained  by  the
Department  of  Ophthalmology  at  the  Second  Affiliated
Hospital  of  Harbin  Medical  University  (Harbin,  China).
Informed  consent  in  accordance  with  the  Declaration  of
Helsinki and the Heilongjiang Institutional Review Board
approval was obtained from all participants. The pedigree was
a four-generation family with three affected members, six
unaffected family individuals, and two spouses (Figure 1).
Genomic  DNA  was  extracted  from  leukocytes  of  their
peripheral blood by standard procedures. Clinical diagnosis
of MCD for these patients was based on pedigree structure
and  clinical  features,  which  include  bilateral  symmetric
stromal cloudiness studded by small, irregular, rounded, gray-
white anterior stromal patches. One hundred normal Chinese
samples were collected as the control.
Special stain and ultrastructural features: A half section of
the corneal button obtained from the proband by penetrating
Figure 1. Pedigree of a Chinese family including three individuals
affected with MCD. Open symbols indicate clinically unaffected
members, filled symbols indicate clinically affected members, and
the arrow indicates the proband.
keratoplasty was fixed in 4% formaldehyde then made into
paraffin-embedded samples stained with Hale’s Colloidal iron
(Maxim IHC World, Fuzhou, China). After being fixed in
2.5% buffer glutaraldehyde, the other half section was washed
with PBS, fixed in 4% osmium tetroxide, dehydrated in the
alcohol, and embedded by routine epoxy resin from which
ultrathin sections were cut and stained with uranyl acetate and
lead  citrate.  The  sections  were  examined  with  light
microscope (LM) and electron microscope (EM).
Mutation analysis: The unique exon involving the coding
region, exon 3, was amplified using polymerase chain reaction
(PCR) with the primers described previously [11]. The cycling
program started with an initial denaturing step of 5 min at
95 °C followed by 33 cycles of 94 °C for 30 s, 53–57 °C for
30 s, and 72 °C for 45 s with a final extension step at 72 °C
for  10  min.  PCR  products  were  purified  and  directly
sequenced  on  both  strands  by  using  an  automatic  DNA
sequencer (ABIPrism 377XL; Applied Biosystems, Foster
City, CA).The nucleotide sequences were compared with the
published cDNA sequence of CHST6 (NM_021615).
Restriction  enzyme  digestion:  Two  enzymes,  PvuII  with
recognition  site  5′…CAGˇCTG…3′  and  PmacI  with
recognition site 5′… CACˇGTG… 3′, were used for all family
individuals  to  confirm  the  two  heterozygous  mutations
identified  by  sequencing  c.  892C>T  and  c.1072T>C,
respectively. To exclude the possibility that the mutations
were polymorphisms, the PCR products from 100 control
subjects were also analyzed by those restriction enzymes.
After digestion with PvuII and PmacI, the PCR products were
electrophoresed by 6% nondenaturing polyacrylamide gel and
visualized by staining with 0.2% AgNO3.
RESULTS
Clinical  findings:  Slit  lamp  examination  of  the  affected
individuals showed that stromal cloudiness were studded by
irregular rounded gray-white opacities in both the central and
peripheral cornea (Figure 2). The corneal opacities were deep
into  corneal  stroma  anterior,  the  endothelial  layer,  and
Descemet’s membrane.
Exhibition of histopathology: From light microscopic study,
plaque deposits were diffusely found in the corneal stroma and
even  near  the  endothelium.  They  presented  significant
positive reaction to Hale’s colloidal iron stain, which was
indicated by extracellular blue accumulations in the stroma.
(Figure 3).
Under  transmission  electron  microscopy,  it  was
displayed that the collagen fibers in the corneal stroma were
irregular, enlarged, and intensive and the fibroblasts were
active  and  hyperplastic.  The  enlargement  of  the  smooth
endoplasmic  reticulum  and  intracytoplasmic  vacuoles
appeared within those cells (Figure 4).
Results of sequencing: CHST6 is 16.9 kb in length and consists
of four exons of which only exon 3 contains the coding region.
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701Two mutations, c. 892C>T and c. 1072T>C, were identified
on each allele of exon 3. The first heterozygous change from
the maternal allele, a c. 892C>T transition, occurred at the first
nucleotide  position  of  codon  298,  predicting  a  change  of
amino acid glutamine to a stop codon (p.Q298X). The other
change on the paternal allele, a c. 1072T>C transition, was
identified at the second nucleotide position of codon 358,
changing the amino acid from tyrosine to histidine (p.Y358H;
Figure 5). Each patient (III:2, III:4, and III:6) in this family
was found to have these two mutations within CHST6. The
unaffected individuals II-2, III:1, and IV-1 were heterozygous
with  the  nonsense  change,  c.  892C>T,  while  the  other
Figure 2. A photograph of the right eye of the proband. It shows
stromal cloudiness studded by irregular rounded gray-white opacities
in the central and peripheral cornea.
Figure 3. Paraffin section of the proband’s cornea stained with Hale’s
colloidal iron. Blue plaque deposits were found in the corneal stroma
and  under  the  endothelial  layer.  These  deposits  presented  a
significantly positive reaction to colloidal iron staining.
unaffected individuals II-3, III-5, and IV-2 were heterozygous
with the missense change, c. 1072T>C.
Restriction enzyme digestion: PCR products from individuals
with c.892C>T transition were digested into 153 bp and 173
bp by restriction enzyme, PvuII, whereas ones without c.
892C>T transition only had a 153 bp segment. Sequence with
c.1072T>C transition could be divided into 337 bp and 357
bp by PmacI, but those without c.1072T>C transition only had
a 357 bp segment. In addition, the results showed that the two
heterozygous restriction enzyme segments segregated with all
affected members.
PCR products from 100 control subjects were analyzed
by  the  same  two  restriction  enzymes,  but  no  mutation
segments were found among them (Figure 6, Figure 7).
DISCUSSION
Macular corneal dystrophy is the least common of the classic
stromal  dystrophies.  This  disorder  is  more  common  in
Iceland, however, representing the most frequent indication
for penetrating keratoplasty [21]. In the present study, we
collected one pedigree with three patients clinically diagnosed
with MCD. Slit lamp examination of the affected individuals
showed  corneal  opacities  and  stromal  haze,  which  were
common characteristic of MCD as described elsewhere [3,
22].
Sequence analysis of the CHST6 coding region revealed
compound heterozygous mutations, c.892 C>T and c.1072T
>C, co-segregated with the disease in the pedigree, which
resulted in a missense mutation (p.Y358H) and an early stop
codon  (p.Q298X),  respectively,  and  implied  MCD  as  a
recessive inherited disorder. Each patient (III:2, III:4, and III:
Figure 4. Transmission electron microscopy result of paraffin section
of the proband’s cornea stained with Hale's colloidal iron. A: The
picture shows that the collagen fibers in the corneal stroma are
irregular, enlarged, and intensive (1,500X). B: The picture shows
hyperplastic, active fibroblasts and intracytoplasmic vacuoles in the
cornea (5,000X).
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mutations.  Six  unaffected  blood  related  members  carried
either one of the two mutations. None of these nucleotide
alterations were detected in the 100 normal control subjects,
indicating that these variations were not polymorphisms.
The CHST6 protein is a sulfotransferase, a carbohydrate
sulfotransferase of the semi-methyl-D/N-acetyl-galactose/N-
acetyl glucosamine-6-O-sulfotransferase family, which can
catalyze the phosphorylation of 6-hydroxy-6-O of N-acetyl
glucosamine, galactose, and N-acetyl galactosamine. In the
normal corneal tissue, keratan sulfate (KS) is an important
glycosaminoglycan, which exists as a highly sulfated form
and plays a crucial role in the structure and transparency of
the cornea. CHST6 can transfer the sulfuric acid group from
the  3′-adenosine  5′-phosphate  acid  (PAPS)  to  the  KS  by
competing with an endogenous or exogenous substrate [23].
The variations in the coding region of CHST6 may decrease
activity of the enzyme or even make it lost, leading to a low
sulfated form or non-sulfated form of KS. Due to the loss of
it's  soluble  property,  non-sulfated  KS  is  unable  to  be
completely metabolized, inducing sediment to deposit in the
corneal stroma [24].
The  nonsense  change  (p.Q298X)  resulted  in  the
premature termination of protein transcription and truncated,
dysfunctional protein products. Sultana [11] and Ha [12] also
found other nonsense mutations in the gene and thought that
Figure  5.  Direct  sequencing  analysis  of  the  coding  region  of
CHST6. A: Normal sequence at codon 298. B: Sequence of the
coding region of CHST6 in the proband revealed a change of the
nucleotide  at  codon  298  (CAG→TAG).  C:  Normal  sequence  at
codon 358. D: Sequence of the coding region of CHST6 in the
proband showed a substitution at codon 358 (TAC→CAC).
the truncated protein was instable and could be degraded
rapidly, which was related to the MCD phenotype [14]. The
p.Y358H mutation is a new missense mutation that changes
tyrosine  to  histidine,  inducing  the  substitution  between  a
neutral amino acid into a basic amino acid. In 2005, El-Ashry
[25] found the p.Y358D mutation (tyrosine to aspartate) in the
patients with MCD type I, which changes from a neutral amino
acid into an acidic amino acid. The tyrosine at codon 358 is
highly  conservative  in  many  eukaryotic  species  such  as
human, canine, chimpanzee, rat, mouse, and drosophila, using
bioinformatic  analysis.  So  we  speculated  that  the  Y358H
mutation could also affect the protein function [26].
Figure  6.  PvuII  digestion  of  PCR  products  for  the  c.892C>T
transition. PCR products in individuals with the c.892C>T transition
were digested into 153 bp and 173 bp and into only 153 bp in
individuals without the c.892C>T transition. A: Members of the
Chinese family with MCD. PCR products from individuals II:2, III:
1, III:2, III:4, III:6 and IV:1 with c.892C>T transition were digested
into 153bp and 173bp, other members without c.892C>T transition
only had a 153bp segment. B :Part of 100 control subjects. Control
subjects without c.892C>T transition only had a 153bp segment. M
indicates DNA ladder, U indicates undigested PCR product, and P
indicates one patient with MCD in the Chinese family.
Figure 7. PmacI digestion of PCR products with for the c.1072T>C
transition.  PCR  products  in  individuals  with  the  c.1072T>C
transition were digested into 337 bp and 357 bp and into only 357bp
in individuals without the c.1072T>C transition. A: Members of the
Chinese family with MCD. PCR products from individuals II:3, III:
2, III:4, III:5, III:6 and IV:2 with c.1072T>C transition were digested
into 337bp and 357bp, other members without c.1072T>C transition
only had a 357bp segment. B: Part of 100 control subjects. Control
subjects without c.1072T>C transition only had a 357bp segment. U
indicates undigested PCR product, and P indicates one patient in the
Chinese family with MCD.
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703Thus, in our study, KS was observed to deposit in the
cornea extensively and deeply, which should be associated
with severe abnormalities of the sulfotransferase, leading to
little activity and lack of function. As detected by microscopy,
plaque accumulations (significant positive reaction to Hale’s
colloidal iron stain) diffusely appeared in the corneal stroma
and even close to the endothelium. They were likely to be
made up of the enlarged and intensive collagen fibers and
active, hyperplastic fibroblasts that attempted to ingest the
abnormal sediment, which caused the enlargement of smooth
endoplasmic reticulum and the presence of intracytoplasmic
vacuoles in the cells.
The  mutations  identified  in  this  Chinese  family  are
completely different from those reported previously in other
Asians (Japanese) [10] or whites (British and Icelandic) [11,
22].  Together  with  previous  reports,  our  data  indicate
significant  allelic  heterogeneity  exists  in  MCD  and  the
essential role of CHST6 in the transparency of the cornea. The
immunophenotype of MCD has not been performed in our
study since we could not test the serum level of KS. Yet no
matter the type of MCD, all have indistinguishable clinical
characteristic and the same responsible gene. Further studies
on these mutations would be helpful to achieve a clearer
understanding of the molecular mechanisms of MCD.
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